Dhanuka Agritech reported a challenging Q1 FY27 due to delayed monsoons and pricing pressures.

Revenue dropped 12.56% to Rs. 461.93 Cr, with EBITDA at Rs. 55.01 Cr and PAT at Rs. 36.30 Cr.

Herbicide sales were notably impacted, though certain fungicides saw growth.

Management is optimistic for upcoming quarters, highlighting strategic investments: a new Rs. 200 Cr automated formulation plant in Nagpur by April 2028, and five new product launches planned.

The company is actively expanding its global reach for Bayer-acquired products.

Dialogue confirmed confidence in winning a GST notice case.

Despite short-term headwinds, focus remains on innovation and long-term value.